Research and Markets has announced the addition of the "Connected Drug Delivery - Devices, Markets, Players, Strategies and Forecasts" report to their offering.
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life.
Connected devices - drug delivery devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.
What You Will Learn
Key Topics Covered:
1. Executive Summary
2. Connected Devices - The Opportunity
3. Wireless Connectivity Technologies
4. Wirelessly Connected Device Analysis
5. Near-term Markets and Applications
6. Market Factors
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/v354ft/connected_drug
View source version on businesswire.com: http://www.businesswire.com/news/home/20161026006209/en/Business Wire
Last updated on: 26/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.